Vaccitech plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
For the six months, revenue was USD 0.802 million compared to USD 32.08 million a year ago. Net loss was USD 41.98 million compared to net income of USD 18.29 million a year ago. Basic loss per share from continuing operations was USD 1.1 compared to basic earnings per share from continuing operations of USD 0.49 a year ago. Diluted loss per share from continuing operations was USD 1.1 compared to diluted earnings per share from continuing operations of USD 0.48 a year ago.